Early recurrence factors in patients with stage III non‐small cell lung cancer treated with concurrent chemoradiotherapy

Early recurrence factors in patients with stage III non‐small cell lung cancer treated with concurrent chemoradiotherapy

Abstract Background The clinical characteristics and risk factors for cancer recurrence have not been well evaluated regarding early recurrence in patients with unresectable locally advanced non‐small cell lung cancer (LA‐NSCLC) who receive concurrent chemoradiotherapy (CRT). The aim of this study w...

Full description

Bibliographic Details
Main Authors: Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Thoracic Cancer
Subjects:
body mass index
chemoradiotherapy
neoplasm recurrence
non‐small cell lung carcinoma
tumor proportion score
Online Access:https://doi.org/10.1111/1759-7714.14704

Internet

https://doi.org/10.1111/1759-7714.14704

Similar Items